申请人:Ironwood Pharmaceuticals, Inc.
公开号:EP3181566A1
公开(公告)日:2017-06-21
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including CNS or neurodegeneration disorder.
本发明提供的咪唑三嗪酮化合物是磷酸二酯酶9的抑制剂。本发明进一步提供了这些化合物在治疗哺乳动物中与 PDE9 相关的疾病或紊乱(包括中枢神经系统或神经变性紊乱)中的工艺、药物组合物、药物制剂和药物用途。